A share price of Oncology Institute Inc [TOI] is currently trading at $0.55, up 13.40%. An important factor to consider is whether the stock is rising or falling in short-term value. The TOI shares have gain 82.30% over the last week, with a monthly amount glided 179.47%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Guggenheim started tracking the stock with Buy rating on September 14, 2022, and set its price target to $7. On August 15, 2022, Jefferies initiated with a Buy rating and assigned a price target of $10 on the stock.
Oncology Institute Inc experienced fluctuations in its stock price throughout the past year between $0.13 and $2.45. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Oncology Institute Inc [NASDAQ: TOI] shares were valued at $0.55 at the most recent close of the market. An investor can expect a potential return of 1354.55% based on the average TOI price forecast.
Analyzing the TOI fundamentals
Trailing Twelve Months sales for Oncology Institute Inc [NASDAQ:TOI] were 378.93M which represents 21.78% growth. Gross Profit Margin for this corporation currently stands at 0.13% with Operating Profit Margin at -0.17%, Pretax Profit Margin comes in at -0.19%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -1.77 and Total Capital is -0.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 7.94.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4539 points at the first support level, and at 0.3578 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6322, and for the 2nd resistance point, it is at 0.7144.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Oncology Institute Inc [NASDAQ:TOI] is 2.49. On the other hand, the Quick Ratio is 2.27, and the Cash Ratio is 1.01. Considering the valuation of this stock, the price to sales ratio is 0.11, the price to book ratio is 2.68.
Transactions by insiders
Recent insider trading involved Hively Brad, Director, that happened on Nov 26 ’24 when 0.25 million shares were purchased. Director, Hively Brad completed a deal on Dec 02 ’24 to buy 50000.0 shares. Meanwhile, 10% Owner Havencrest Healthcare Partners sold 8637.0 shares on Jan 29 ’24.
